These data were consistent with what was observed in mice infected soon after vaccination and strongly suggested that in the vaccinated mice, CD8+ T-cell-specific antiviral immunity in the lungs benefits poorly from the breakthrough infection. The gene discussed is CD8A; the disease is infection.